Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Sep
3
2015
Update in Amgen v. Sandoz re: Biosimilar Applications Michael Best & Friedrich LLP
Sep
2
2015
Minnesota Federal Court Finds “Field Preemption” of Minnesota Drug Testing Statute Jackson Lewis P.C.
Sep
1
2015
Makers’ Mark Two: Bourbon Distiller Slips another “Handmade” False Advertising Suit Proskauer Rose LLP
Sep
1
2015
Wait Continues for Release of First FSMA Final Rules Armstrong Teasdale
Sep
1
2015
FDA’s New Four-Letter Guidance on Biosimilars Mintz
Aug
31
2015
Getting Serious about Palcohol: Powdered Alcohol Faegre Drinker
Aug
31
2015
An Update on Biosimilar Activity in the U.S. Michael Best & Friedrich LLP
Aug
30
2015
Another FTC Conduct Case to Bolster Generic Drug Competition: Pharmaceuticals Charged with Illegal Non-Compete for Generic ADHD Drug Sales Mintz
Aug
28
2015
What’s in a Name? That Which We Call a Biological Product… Sheppard, Mullin, Richter & Hampton LLP
Aug
28
2015
FDA’s Proposed Naming Convention for Biologics Foley & Lardner LLP
Aug
28
2015
Health Resources and Service Administration (HRSA) Issues Proposed “Omnibus Guidance” Epstein Becker & Green, P.C.
Aug
28
2015
Amgen Inc., et al. v. Sandoz, Inc.: Shall Means Shall . . . Unless It Doesn’t McDermott Will & Emery
Aug
27
2015
Food Standards of Identity Remain a Focus of FDA Regulatory Action Michael Best & Friedrich LLP
Aug
27
2015
Sixth Circuit Assesses Class Action Criteria in Digestive Drug Litigation Squire Patton Boggs (US) LLP
Aug
27
2015
Amgen And Apotex Do The Biosimilar Patent Dance Foley & Lardner LLP
Aug
26
2015
Kyle Bass Loses Round 1 Of IPR Attack Against Pharma/Biotech Patents Foley & Lardner LLP
Aug
26
2015
Trademarking: Capri Sun Says “Respect the Pouch” IMS Legal Strategies
Aug
26
2015
State Pharmaceutical Pricing Disclosure Laws: Old Story, New Refrain Mintz
Aug
26
2015
AmerisourceBergen Guest Post: Solutions to Overcome Reimbursement Challenges in Personalized Medicine Foley & Lardner LLP
Aug
26
2015
Litigation Fallout From All This Supply Chain Transparency Legislation (Or, These Things Have Teeth!) (Or, The Cycle of Misfortune) Squire Patton Boggs (US) LLP
Aug
25
2015
FDA Flunks Mylan’s India Facilities, Finds cGMP Violations Mahany Law
Aug
25
2015
PTAB Denies Institution Of Kyle Bass's Ampyra Patent Challenge Foley & Lardner LLP
Aug
24
2015
Protecting Diagnostic Innovation – Two Actor Infringement Liability Foley & Lardner LLP
Aug
21
2015
New Guide On Safety Assessments of NIAS in Food-Contact Materials Available from ILSI Europe Keller and Heckman LLP
Aug
21
2015
Off-Label Marketing and False Claims Act Mintz
Aug
21
2015
FDA Adds Three New Substances to Its Inventory of Effective FCS Notifications Keller and Heckman LLP
Aug
21
2015
Food Court Report: Consumer Claims Targeting Trans Fat In Instant Noodles Case Survive Motion To Dismiss Keller and Heckman LLP
Aug
20
2015
Italian Medicines Agency Makes Public Assessment Reports Available on its Website Covington & Burling LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins